How thyroid hormone works depends upon cell type, receptor type, and hormone analogue: implications in cancer growth

Area of Science:

• Endocrinology
• Molecular Biology
• Cancer Research

Background:

• The classical thyroid hormone pathway involves intranuclear receptors and gene expression, primarily observed in normal cells.
• Thyroid hormones, including L-thyroxine (T4) and 3,5,3′-triiodo-L-thyronine (T3), play crucial roles in cellular function.
• Alternative signaling pathways for thyroid hormones exist, particularly in non-traditional cellular contexts.

Purpose of the Study:

• To highlight the distinct mechanisms of thyroid hormone action based on cell type.
• To investigate the role of plasma membrane integrin αvβ3 in mediating thyroid hormone effects.
• To explore the impact of T4 on cancer cell proliferation, metabolism, angiogenesis, and platelet activation.

Main Methods:

• Focus on the cellular response to L-thyroxine (T4) binding to plasma membrane integrin αvβ3.
• Analysis of T4's modulation of gene transcription in intact tumor cells.
• Investigation of T4's regulation of integrin interactions with vascular growth factor receptors in endothelial cells.
• Examination of T4-mediated platelet activation via αvβ3.

Main Results:

• Cancer cells, dividing endothelial cells, phagocytes, and platelets respond to T4 via integrin αvβ3.
• T4 binding to integrin αvβ3 modulates gene transcription related to cancer cell proliferation, metabolism, and apoptosis.
• T4 influences angiogenesis by regulating integrin interactions with vascular growth factor receptors.
• T4 activates platelets through αvβ3, which is transferred from megakaryocytes.
• Reverse T3 (rT3) may also act on cancer cells via the thyroid hormone receptor on αvβ3.

Conclusions:

• Thyroid hormone action is cell-type dependent, with a significant plasma membrane-based pathway involving integrin αvβ3.
• This alternative pathway is crucial for T4's effects on cancer biology, including proliferation, metabolism, and angiogenesis.
• Integrin αvβ3 serves as a key receptor for T4 in various cell types, including platelets and cancer cells.